Terns Pharmaceuticals, Inc. TERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

3/6 Pass

SharesGrow Intrinsic Value

Terns Pharmaceuticals, Inc. (TERN) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Vivo Capital Surplus Fund VIII, L.P. 3,581,592 株保有. その他の主要保有者には ORBIMED ADVISORS LLC および GORDON CARL L.

過去12ヶ月間にインサイダーは 29 件の取引を実施 TERN 株式 — 20 件の買い (評価額 $1.75M) および 8 件の売り (評価額 $1.11M). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

TERN インサイダー保有状況

最大保有者

Vivo Capital Surplus Fund VIII, L.P.

3,581,592 株

買い（12ヶ月）

$1.75M 評価額

売り（12ヶ月）

$1.11M 評価額

12ヶ月取引活動

買い 69%

売り 28%

インサイダー上位保有者

#	氏名	役職	保有株数	最終申告日	相対規模
1	Vivo Capital Surplus Fund Viii, L.p.	Director	3,581,592	2022-09-08	100%
2	Orbimed Advisors Llc	10 Percent Owner	756,258	2024-07-17	21%
3	Gordon Carl L	10 Percent Owner	756,258	2024-07-17	21%
4	Aden Matthew J	SVP Worldwide Sales	500,000	2005-08-02	14%
5	Lav Biosciences Fund V, L.p.	Director	405,583	2022-11-28	11%
6	Burroughs Amy L.	Chief Executive Officer	288,976	2026-03-17	8%
7	Vivo Opportunity, Llc	10 Percent Owner	275,772	2024-04-03	8%
8	Russell Kerry Strong	Chief Medical Officer	240,000	2022-07-06	7%
9	Chase Jerry D	Chief Executive Officer	239,520	2004-09-10	7%
10	Taylor Arthur T	SVP, CFO	125,000	2003-05-30	3%
11	Kuriakose Emil	Chief Medical Officer	105,673	2026-04-02	3%
12	Gengos Andrew	Chief Financial Officer	101,788	2026-01-16	3%
13	Yoon Seokho Bryan	COO and General Counsel	91,940	2024-06-04	3%
14	Vignola Mark J.	Chief Financial Officer	83,811	2025-01-06	2%
15	Quirk Erin	President, Head of R&d	75,000	2024-01-25	2%
16	Lu Hongbo	Director	45,000	2025-06-12	1%
17	Orbimed Genesis Gp Llc	Director	38,450	2022-08-18	1%
18	Sundaram Senthil Vel	Chief Executive Officer	9,770	2023-06-02	0%
19	Taylor Ann Elizabeth	Director	4,676	2024-07-02	0%
20	Solomon Lewis	Director	3,000	2005-02-18	0%

最近の取引 (過去12ヶ月)

日付	氏名	役職	種類	株数	株価	価値
2026-04-01	Kuriakose Emil	Chief Medical Officer	情報に基づく売り	942	$52.75	$49.69K
2026-03-16	Burroughs Amy L.	Chief Executive Officer	情報に基づく売り	2,770	$47.30	$131.03K
2026-02-17	Burroughs Amy L.	Chief Executive Officer	情報に基づく売り	4,083	$39.80	$162.5K
2026-02-01	Quigley Jill M.	Director	RSU 付与（制限付株式）	1,697	$34.60	$58.72K
2026-02-01	Tripuraneni Radhika	Director	RSU 付与（制限付株式）	1,697	$34.60	$58.72K
2026-02-01	Azelby Robert	Director	RSU 付与（制限付株式）	1,697	$34.60	$58.72K
2026-02-01	Turner Heather D	Director	RSU 付与（制限付株式）	1,697	$34.60	$58.72K
2026-02-01	Kindler Jeffrey B	Director	RSU 付与（制限付株式）	1,697	$34.60	$58.72K
2026-02-01	Fellows David A	Director	RSU 付与（制限付株式）	2,828	$34.60	$97.85K
2026-01-14	Kuriakose Emil	Chief Medical Officer	RSU 付与（制限付株式）	56,250	-	-
2026-01-15	Burroughs Amy L.	Chief Executive Officer	情報に基づく売り	7,521	$37.53	$282.23K
2026-01-14	Burroughs Amy L.	Chief Executive Officer	RSU 付与（制限付株式）	150,000	-	-
2026-01-14	Gengos Andrew	Chief Financial Officer	RSU 付与（制限付株式）	68,750	-	-
2026-01-02	Kuriakose Emil	Chief Medical Officer	情報に基づく売り	955	$38.36	$36.63K
2026-01-05	Burroughs Amy L.	Chief Executive Officer	オプション行使（売却）	150,000	-	-
2026-01-02	Burroughs Amy L.	Chief Executive Officer	オプション行使	21,551	$4.64	$100K
2025-11-04	Quigley Jill M.	Director	情報に基づく売り	24,520	$18.00	$441.36K
2025-10-01	Kuriakose Emil	Chief Medical Officer	情報に基づく売り	944	$7.85	$7.41K
2025-07-01	Kuriakose Emil	Chief Medical Officer	情報に基づく売り	853	$4.27	$3.64K
2025-06-27	Gengos Andrew	Chief Financial Officer	情報に基づく買い	5,000	$3.93	$19.63K
2025-06-25	Burroughs Amy L.	Chief Executive Officer	情報に基づく買い	23,314	$3.87	$90.23K
2025-06-16	Gengos Andrew	Chief Financial Officer	情報に基づく買い	5,000	$3.95	$19.73K
2025-06-13	Gengos Andrew	Chief Financial Officer	情報に基づく買い	5,000	$3.75	$18.75K
2025-06-11	Quigley Jill M.	Director	RSU 付与（制限付株式）	45,000	$4.10	$184.5K
2025-06-11	Lu Hongbo	Director	RSU 付与（制限付株式）	45,000	$4.10	$184.5K